(Q35266077)

7 August 2017

1 reference

title

Molecular insights into human immunodeficiency virus type 1 pathogenesis (English)

1 reference

7 August 2017

M. B. Feinberg

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1356348

17 September 2022

W. C. Greene

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1356348

17 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1356348

17 September 2022

publication date

1 August 1992

1 reference

Current Opinion in Immunology

7 August 2017

published in

1 reference

7 August 2017

volume

4

1 reference

7 August 2017

issue

4

1 reference

7 August 2017

page(s)

466-474

1 reference

HIV revealed: toward a natural history of the infection

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980041-5

7 January 2021

Transient High Levels of Viremia in Patients with Primary Human Immunodeficiency Virus Type 1 Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980041-5

7 January 2021

High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980041-5

7 January 2021

The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980041-5

7 January 2021

Viral DNA and mRNA expression correlate with the stage of human immunodeficiency virus (HIV) type 1 infection in humans: evidence for viral replication in all stages of HIV disease

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980041-5

7 January 2021

Few infected CD4+ T cells but a high proportion of replication-competent provirus copies in asymptomatic human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980041-5

7 January 2021

Plasma viremia in human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980041-5

7 January 2021

Quantitation of human immunodeficiency virus type 1 in the blood of infected persons

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980041-5

7 January 2021

High-Level Viremia in Adults and Children Infected with Human Immunodeficiency Virus: Relation to Disease Stage and CD4+ Lymphocyte Levels

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980041-5

7 January 2021

Increasing viral burden in CD4+ T cells from patients with human immunodeficiency virus (HIV) infection reflects rapidly progressive immunosuppression and clinical disease

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980041-5

7 January 2021

Predicting progression to AIDS: combined usefulness of CD4 lymphocyte counts and p24 antigenemia

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980041-5

7 January 2021

The molecular biology of human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980041-5

7 January 2021

NIH conference. Immunopathogenic mechanisms in human immunodeficiency virus (HIV) infection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980041-5

7 January 2021

Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980041-5

7 January 2021

HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980041-5

7 January 2021

The viral envelope gene is involved in macrophage tropism of a human immunodeficiency virus type 1 strain isolated from brain tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980041-5

7 January 2021

HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980041-5

7 January 2021

Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980041-5

7 January 2021

Incompletely reverse-transcribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the retroviral life cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980041-5

7 January 2021

The DNA binding subunit of NF-kappa B is identical to factor KBF1 and homologous to the rel oncogene product

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980041-5

7 January 2021

DNA binding and I kappa B inhibition of the cloned p65 subunit of NF-kappa B, a rel-related polypeptide

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980041-5

7 January 2021

Isolation of a rel-related human cDNA that potentially encodes the 65-kD subunit of NF-kappa B.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980041-5

7 January 2021

The v-rel oncogene encodes a kappa B enhancer binding protein that inhibits NF-kappa B function

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980041-5

7 January 2021

A novel mitogen-inducible gene product related to p50/p105-NF-kappa B participates in transactivation through a kappa B site

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980041-5

7 January 2021

Cloning of an NF-kappa B subunit which stimulates HIV transcription in synergy with p65

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980041-5

7 January 2021

RelB, a new Rel family transcription activator that can interact with p50-NF-kappa B.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980041-5

7 January 2021

Dorsal, an embryonic polarity gene in Drosophila, is homologous to the vertebrate proto-oncogene, c-rel.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980041-5

7 January 2021

I kappa B: a specific inhibitor of the NF-kappa B transcription factor

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980041-5

7 January 2021

Characterization of an immediate-early gene induced in adherent monocytes that encodes IκB-like activity

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980041-5

7 January 2021

Functional characterization of the NF-kappa B p65 transcriptional activator and an alternatively spliced derivative

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980041-5

7 January 2021

Cells nonproductively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression: a molecular model for latency

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980041-5

7 January 2021

Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: evidence for differential gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980041-5

7 January 2021

Functional dissection of the HIV-1 Rev trans-activator—Derivation of a trans-dominant repressor of Rev function

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980041-5

7 January 2021

Inhibition of HIV replication in acute and chronic infections in vitro by a Tat antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980041-5

7 January 2021

Importance of the nef gene for maintenance of high virus loads and for development of AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980041-5

7 January 2021

Serine phosphorylation-independent downregulation of cell-surface CD4 by nef

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980041-5

7 January 2021

Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980041-5

7 January 2021

Early T-helper cell defects in HIV infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980041-5

7 January 2021

Immunological and virological markers in individuals progressing from seroconversion to AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980041-5

7 January 2021

A superantigen encoded in the open reading frame of the 3' long terminal repeat of mouse mammary tumour virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980041-5

7 January 2021

Clonal deletion of V beta 14-bearing T cells in mice transgenic for mammary tumour virus

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980041-5

7 January 2021

A virus-encoded "superantigen" in a retrovirus-induced immunodeficiency syndrome of mice

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980041-5

7 January 2021

The staphylococcal enterotoxins and their relatives.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980041-5

7 January 2021

Selective depletion in HIV infection of T cells that bear specific T cell receptor V beta sequences

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980041-5

7 January 2021

Replication of an acutely lethal simian immunodeficiency virus activates and induces proliferation of lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980041-5

7 January 2021

Antigenic Diversity Thresholds and the Development of AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980041-5

7 January 2021

10.1016/S0952-7915(06)80041-5

Identifiers

DOI

1 reference

7 August 2017

1 reference